Page 1

Albertsons Companies Albertsons® Companies , Inc. Reports Second Quarter Fiscal 2026 Results Accelerates Turnaround and Cost Savings Efforts BOISE , Idaho - October 13 , 2026 - Albertsons® Companies , Inc. ( NYSE : ACI ) ( the " Company " ) today reported results for the second quarter of fiscal 2026 , which ended September 12 , 2026 . Second Quarter of Fiscal 2026 Highlights • Identical sales decreased 0.8 % • Digital sales increased 11 % • Net income of $ 52 million , or $ 0.11 per share • Adjusted net income of $ 179 million , or $ 0.36 per share • Adjusted EBITDA of $ 784 million " Although our second quarter performance was in - line with the expectations in our revised outlook , our results do not reflect the potential of the Company , " said Susan Morris , Chief Executive Officer . " We are launching a comprehensive business review to speed up improvements in Albertsons ' performance and tackle even harder a cost structure we can no longer afford . Our work will find opportunities to simplify the organization , improve decision - making , reinvest savings in customer value , and boost long - term shareholder returns . " Second Quarter of Fiscal 2026 Results Net sales and other revenue decreased 0.1 % to $ 18,894.7 million for the 12 weeks ended September 12 , 2026 ( " second quarter of fiscal 2026 " ) from $ 18,915.8 million during the 12 weeks ended September 6 , 2025 ( " second quarter of fiscal 2025 " ) . This decrease was driven by a decline in identical sales of 0.8 % . Pharmacy and digital remained areas of strength , with pharmacy sales continuing to grow despite ongoing Inflation Reduction Act ( " IRA " ) headwinds and digital sales increasing 11 % during the second quarter of fiscal 2026. The decrease in Net sales and other revenue was partially offset by higher fuel sales . Gross margin rate decreased to 26.8 % during the second quarter of fiscal 2026 compared to 27.0 % during the second quarter of fiscal 2025. Excluding the impact of fuel and LIFO expense , gross margin rate decreased 17 basis points compared to the second quarter of fiscal 2025. This decrease was primarily driven by increases in delivery and handling costs related to the continued growth in digital sales , as well as higher shrink . These impacts were partially offset by improvements in pharmacy margins , primarily related to the impact of the IRA . The Company also continued to make incremental investments in its customer value proposition , funded by productivity initiatives . Selling and administrative expenses increased to 25.6 % of Net sales and other revenue during the second quarter of fiscal 2026 compared to 25.4 % during the second quarter of fiscal 2025. Excluding the impact of fuel , Selling and administrative expenses as a percentage of Net sales and other revenue increased 38 basis points . This increase in Selling and administrative expenses as a percentage of Net sales and other revenue was primarily attributable to sales deleveraging resulting from lower identical sales . Selling and administrative expenses were relatively flat year over year as the Company continued to realize benefits from disciplined productivity and cost management initiatives which offset inflationary pressures on operating expenses and increases in merger - related litigation costs .